ÂÜÀòÂÒÂ×

Shelly Leibman Barak is a seasoned professional in clinical development and pharmacology with extensive experience in the pharmaceutical industry. Currently serving as the Director of Clinical Development at Kamari Pharma since May 2022, Shelly previously held various positions at Neuroderm from December 2015 to May 2022, including Clinical Science Manager, Clinical Pharmacology Scientist, and Research Unit Manager. Prior roles include SRA positions at the Ernest Gallo Clinic and Research Center and UC Berkeley. Shelly earned multiple Master of Science degrees in Neuroscience and Neurobiology from Tel Aviv University, where also obtained a Bachelor of Science degree in Biology.